CAS No. 1826843-81-5 (ADC)
Chemical Structure
Check the
Trastuzumab-deruxtecan (DS-8201a, T-DXd)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Chemical Information
| CAS Number | 1826843-81-5 (ADC) | |
|---|---|---|
| Molecular Formula |
N/A |
|
| Molecular Weight (MW) | 153000 |
Biological Activity
Trastuzumab deruxtecan (DS-8201a, T-DXd) is an antibody-drug conjugate targeting human epidermal growth factor receptor 2 (HER2). Upon target binding and receptor endocytosis, its enzymatically cleavable linker releases a potent topoisomerase I inhibitor payload that stabilizes topoisomerase I-DNA complexes. This inhibition causes double-stranded DNA damage, triggering apoptosis and cell cycle arrest while exerting a bystander killing effect on neighboring tumor cells. [1][2]
How to Prepare Stock Solution?
|
Concentration
Volume
Mass
|
|---|
Solubility
Reference
Jump to
- Trastuzumab-deruxtecan (DS-8201a, T-DXd) Clinical Trials
- Trastuzumab-deruxtecan (DS-8201a, T-DXd) Stock Solution
- Trastuzumab-deruxtecan (DS-8201a, T-DXd) Storage
- Trastuzumab-deruxtecan (DS-8201a, T-DXd) Stability
- Trastuzumab-deruxtecan (DS-8201a, T-DXd) Molecular Weight
- Trastuzumab-deruxtecan (DS-8201a, T-DXd) SDS|MSDS
Note: Technical data last updated: Sep 1, 2026.